Evidence map›Paper›PMID 42582033›Full record

ArticleFrontiers in cellular and infection microbiology2026

Clinical utility of CSF metagenomic next-generation sequencing in suspected CNS infection: performance against a composite reference standard and read-count stratification.

Peng Shi, Zhongzheng Liu, Xinyu Wu, FangYu Zhao, Juanjuan Xu, Qianqian Li, Ming Ye, Di Nian

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peng Shi *Department of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Zhongzheng Liu *Department of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Xinyu WuDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
FangYu ZhaoDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Juanjuan XuDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Qianqian Li *Department of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Ming Ye *Department of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Di Nian *Department of Medical Examination, Bengbu Medical University, Bengbu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) is increasingly used to identify pathogens in suspected central nervous system (CNS) infections. However, integrating these results into real-world clinical decision-making remains problematic, particularly given the lack of standardized quantitative metrics beyond raw read counts. Methods: We retrospectively analyzed 46 patients with suspected encephalitis, meningitis, or meningoencephalitis who underwent CSF mNGS testing. Etiologic certainty was classified using a composite clinical reference standard as Definite, Probable, or Unlikely. We assessed concordance between mNGS findings and the Likely etiology category (Definite or Probable), calculated diagnostic performance metrics, characterized the detected pathogens, and explored a tiered interpretation framework based on maximum read counts per patient (<10, 10-49, and >=50). Trends across read-count strata were evaluated using the Cochran-Armitage test, and exact binomial 95% confidence intervals (CIs) were calculated. Results: CSF mNGS detected pathogens in 13 of 46 patients (28.3%). Positivity increased with greater adjudicated diagnostic certainty, from 0% in Unlikely cases to 11.8% in Probable cases and 73.3% in Definite cases. Within the composite reference framework, mNGS showed 40.6% sensitivity, 100% specificity, 100% positive predictive value, and 42.4% negative predictive value, indicating stronger rule-in than rule-out performance. Viral detections predominated, with herpes simplex virus type 1 and varicella-zoster virus as the most frequent pathogens; all findings should be interpreted in the context of DNA-only testing. Among mNGS-positive patients with Likely etiologies, the proportion classified as Definite increased across higher max-read strata, but these tier-specific estimates were imprecise and should be viewed as exploratory. Conclusion: In this real-world cohort, positive CSF mNGS results supported an infectious etiology more strongly than negative results excluded it. Max-read-based stratification may have exploratory interpretive value for positive findings, but it should not be considered a validated clinical decision rule and requires confirmation in larger multicenter studies with standardized reference standards.

Indexed as

Central Nervous System InfectionsCerebrospinal FluidHigh-Throughput Nucleotide SequencingMetagenomicsAdolescentAdultAgedFemaleHumansMaleMeningitisMiddle AgedReference StandardsRetrospective StudiesSensitivity and SpecificityYoung Adultcentral nervous system infectioncerebrospinal fluiddiagnostic performanceinterpretation frameworkmetagenomic next-generation sequencingread count

Identifiers

PMID42582033
PMCPMC13457042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.